PLoS ONE (Jan 2020)

Undefeated-Changing the phenamacril scaffold is not enough to beat resistant Fusarium.

  • Rasmus D Wollenberg,
  • Søren S Donau,
  • Manuel H Taft,
  • Zoltan Balázs,
  • Sven Giese,
  • Claudia Thiel,
  • Jens L Sørensen,
  • Thorbjørn T Nielsen,
  • Henriette Giese,
  • Dietmar J Manstein,
  • Reinhard Wimmer,
  • Teis E Sondergaard

DOI
https://doi.org/10.1371/journal.pone.0235568
Journal volume & issue
Vol. 15, no. 6
p. e0235568

Abstract

Read online

Filamentous fungi belonging to the genus Fusarium are notorious plant-pathogens that infect, damage and contaminate a wide variety of important crops. Phenamacril is the first member of a novel class of single-site acting cyanoacrylate fungicides which has proven highly effective against important members of the genus Fusarium. However, the recent emergence of field-resistant strains exhibiting qualitative resistance poses a major obstacle for the continued use of phenamacril. In this study, we synthesized novel cyanoacrylate compounds based on the phenamacril-scaffold to test their growth-inhibitory potential against wild-type Fusarium and phenamacril-resistant strains. Our findings show that most chemical modifications to the phenamacril-scaffold are associated with almost complete loss of fungicidal activity and in vitro inhibition of myosin motor domain ATPase activity.